| | | |  | If you like to follow news from the nation's capital, STAT's Rachel Cohrs is helping expand D.C. Diagnosis — our newsletter on the politics and policy of biopharma, medicine, and the life sciences writ large — with a Thursday edition. Sign up here for this twice weekly newsletter. | | | | By Paul Fenyves Pfizer via AP Paxlovid was given the green light based on a trial that included only unvaccinated, Covid-naive people. That's a minority of Americans. Read More | | By Steven C. Schlozman Adobe Hopelessness is a major feature of the mental health emergency among youths. Things won't get better without turning around this pessimism. Read More | | Sponsor content by Johnson & Johnson MedTech What does it take to maintain a consistent drumbeat of innovation? Advances in healthcare are moving rapidly as innovative minds fundamentally rethink the future of patient care. Drivers of Innovation is spotlighting the pioneering spirit that enables problem solvers to harness the power of science and technology to address some of healthcare's most pressing challenges and empower everyone to live their best life possible. Meet the bright minds reimagining health. | | By Patrick Skerrett Since March 2020, the @FacesOfCovid Twitter feed has memorialized more than 7,000 Americans who died because of the pandemic. Read More | | By Danielle Wenner and Gabriela Arguedas Ramírez Adobe Public health narratives neglect long Covid, leading those with symptoms to be discounted, marginalized, and subject to other harms. Read More | | By Shoshana Ungerleider Adobe The multitude of "bad" deaths from Covid-19 should renew conversations about improving end-of-life care to aid more "good" deaths. Read More | | By Brian Wallach and Mike Braun Adobe The Promising Pathway Act, crafted with patient input, gives people with life-threatening illnesses timely access to innovative treatments. Read More | | By Martin F. Shapiro and Sidney M. Wolfe Adobe The New England Journal of Medicine and other journals must make conflicts of interest more transparent to readers, or not publish articles. Read More | | By Joe Lieberman and Michelle McMurry-Heath Adobe The U.S. mustn't delay significant investment in innovative chemical, biological, radiological, and nuclear medical countermeasures. Read More | | By Michael L. Millenson and J. Matthew Austin Misha Friedman/Getty Images Maslow's Hierarchy of Needs can help hospitals and health systems better communicate safety information to the public. Read More | |
No comments